In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen-Reference-Cited by-同舟云学术

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen

Published:2002-03 Issue:1 Volume:5 Page:36-46
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Li Y,Tian Z,Rizvi S M A,Bander N H,Allen B J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500543.pdf

Reference65 articles.

1. Landis SH, Murray T, Bolden S, Wingo PA. . Cancer statistics. CA, Cancer J Clin 1998 48: 6–29.

2. Fowler JE Jr, Braswell NT, Pandey P, Seaver L. . Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center. J Urol 1995 153: 1026–1031.

3. Wasson JH et al.. A structural literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. Arch Family Med 1993 2: 487–493.

4. Litwin MS et al.. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol 1998 160: 445–448.

5. Lepor H, Ross A, Walsh PC. . The influence of hormonal therapy on survival of men with advanced prostatic cancer. J Urol 1982 128: 335–340.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer;Seminars in Nuclear Medicine;2023-09

2. The Role of Alpha Therapy in Metastatic Castration Resistance Prostate Cancer;Nuclear Medicine Seminars;2023-09-01

3. Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies);Cancers;2023-07-04

4. Status of α-emitter Radioimmunoconjugates for Targeted Therapy;Current Radiopharmaceuticals;2023-06

5. Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents;Current Radiopharmaceuticals;2023-03